Intermittent Hypoxia-Hyperoxia Combined With Physical Therapy for Knee Osteoarthritis
Key facts
- Who runs it
- Khyber Medical University Peshawar
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 15 May 2025
- Ended
- 22 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Intermittent Hypoxia-Hyperoxia Therapy (IHHT)
- Conventional Physical Therapy
- Normoxic Air Placebo
- Record updated
- 25 June 2026
Who can take part
- Age
- 45 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Participants aged 45 and above
- Participants (both male and female) with knee pain for 3 months or more with any three of the following six items: age of 50 years or more, crepitations, enlarged bone, no palpable warmth, morning stiffness for less than 30 minutes, and bony tenderness
- Patients who can walk and have a minimum score of 4 on the Numeric Pain Rating Scale
- Participants who have intact cognition with a score of 24 and above on Mini Mini- Mental State examination
- Participants able to walk independently for at least 45 meters in the 6-minute walk test
- Participants having a recent X-ray (done within the past 3 months)
Who cannot take part
- Participants with above or below knee surgery or radiating pain to the lower limb
- Patients receiving steroids or any medicine other than that prescribed by the screening orthopaedic surgeon
- Patients with history of epilepsy, pregnancy
- Diagnosed neurological condition that affects lower-limb strength or walk (e.g., stroke/ basal ganglia dysfunction/ trauma)
- Patients with hip or knee arthroplasty
- Patients who refused to participate in the study or to be randomly allocated
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial aims to evaluate the effectiveness of combining intermittent hypoxia-hyperoxia therapy (IHHT) with conventional physical therapy in improving pain, function, gait, balance, and general health among patients with knee osteoarthritis. The study will be conducted at the Physical Therapy Department of Rehman Medical Institute, Peshawar, Pakistan, over a period of one year.
The 2 groups in the trial
- Intermittent Hypoxia-Hyperoxia + Conventional TherapyTreatment being tested
Participants in this group will receive Intermittent Hypoxia-Hyperoxia Therapy (IHHT) administered using a hypoxia generator. Each session will include 4 cycles of 5 minutes of hypoxia (13-15% O₂) followed by 2 minutes of hyperoxia (40% O₂). This therapy will be provided before each conventional physical therapy session. A total of 12 sessions (3 per week for 4 weeks) will be administered. Conventional therapy will follow the current best practices used by physical therapists in tertiary care hospitals in Peshawar.
Treatment: Intermittent Hypoxia-Hyperoxia Therapy (IHHT) and Conventional Physical Therapy
- Conventional Therapy with Normoxic AirExisting treatment, for comparison
Participants in this group will receive only conventional physical therapy along with normoxic air (19.8% O₂) exposure using the same device setup to maintain blinding. They will receive 4 sessions of normoxia (5 minutes) followed by 2 minutes of normoxia as a placebo for IHHT. This will also be done prior to each of the 12 physical therapy sessions (3 per week for 4 weeks).
Treatment: Conventional Physical Therapy and Normoxic Air Placebo
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness of Combining Intermittent Hypoxia-Hyperoxia and Conventional Physical Therapy for Patients With Knee Osteoarthritis: A Randomized Controlled Trial
- Record updated
- 25 June 2026